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För Mikael & Edith  
  
Myocardial ischemia is associated with cellular- and metabolic adjustments 
within the heart, including accumulation of lipids. Myocardial lipids are 
stored in cytosolic droplets, consisting of a core of neutral lipids surrounded by 
a complex surface containing proteins, such as perilipins. Little is known about 
how myocardial lipid content and dynamics affect the function of the 
ischemic heart. 
 
In this study, we investigated cardiac lipid accumulation and the 
consequences of altered lipid storage and metabolism following myocardial 
ischemia.   
 
In Paper I, we investigated lipid accumulation of in a porcine model of 
ischemia/reperfusion and we found that cholesteryl esters accumulate in the 
myocardium following ischemia. The expression of the low density 
lipoprotein receptor (LDLr) and the low density lipoprotein receptor-related 
protein 1 (LRP1) was up-regulated, suggesting that cholesteryl ester uptake 
was mediated by these receptors. 
 
In Paper II, we investigated the role of the lipid droplet protein Perilipin 5 
(Plin5) in the pathophysiology of myocardial ischemia. In humans, we 
showed that a polymorphism in the PLIN5 gene is associated with reduced 
heart function following myocardial ischemia. In mice, Plin5 deficiency 
dramatically reduced the triglyceride content in the heart. Under normal 
conditions, Plin5
–/–
 mice maintained a close to normal heart function by 
decreasing fatty acid uptake and increasing substrate utilization from glucose, 
thus preserving the energy balance. However, during stress or myocardial 
ischemia, Plin5 deficiency resulted in reduced myocardial substrate 
availability, severely reduced heart function and increased mortality.  
 
In Paper III, we investigated the role of Plin2 in lipid storage and cardiac 
function following ischemia. We found that deficiency of Plin2 in mice 
surprisingly resulted in significantly increased levels of triglycerides. The 
heart function was not compromised in Plin2
–/–
 mice in baseline and stress 
conditions. However, heart function was markedly reduced in Plin2
–/–
 mice 
after induced myocardial infarction.  
 
In conclusion, our findings indicate that dysregulation of myocardial lipid 
metabolism and storage influences heart function and survival following 
myocardial ischemia. Furthermore, our findings highlight a role for lipid 
droplet proteins perilipins in cardioprotection following myocardial ischemia. 
 Hjärtinfarkt är en av de vanligaste dödsorsakerna i västvärlden. Vanligen 
beror en hjärtinfarkt på att en blodpropp har bildats och täppt till ett av kärlen 
som försörjer hjärtat. Detta leder till syrebrist i hjärtmuskeln och om 
syrebristen pågår tillräckligt länge dör delen av hjärtat som normalt försörjs 
av det tilltäppta kärlet. När hjärtat drabbas av syrebrist så ställer hjärtat om 
sin metabolism från att främst använda fett till att använda socker, vilket inte 
generar lika mycket energi till hjärtats pumpfunktion som fett. Den 
förändrade metabolismen i hjärtat leder bland annat till att fett börjar lagras in 
i hjärtat i så kallade fettdroppar. Kunskapen om hur hjärtats förändrade 
lagring och hantering av fett påverkar hjärtfunktionen efter en infarkt är 
fortfarande begränsad.  
 
I avhandlingen har vi studerat hur hjärtat påverkas av syrebristen som följer 
en hjärtinfarkt. Vi har studerat vilka typer av fett som lagras in i hjärtat efter 
en infarkt. Vidare har vi studerat hur proteiner som sitter runt fettdropparna i 
hjärtat (perilipiner) påverkar hjärtats funktion efter en infarkt. 
 
Delarbete I. Här har vi undersökt fettinlagring efter en inducerad infarkt i 
grishjärta. Vi upptäckte att hjärtat lagrade in fettet kolesterol i de delar av 
hjärtat som drabbats av syrebrist. Kolesterol är en viktig komponent i 
hjärtcellernas membran, men de ökade nivåer att kolesterol har sannolikt 
ingen funktion för hjärtat och kan vara skadligt. 
 
Delarbete II. Vi har studerat hur Perlipin5 (Plin5) påverkar hjärtfunktion och 
överlevnad efter infarkt. Efter att ha studerat Plin5 i patienter kunde vi visa 
att hur mycket proteins som tillverkades hade betydelse för hjärtfunktionen 
efter att hjärtat drabbats av syrebrist. Vi upptäckte även att avsaknad av Plin5 
hos möss resulterade i kraftigt minskade nivåer att fett i hjärtat. När hjärtat 
var tvunget att arbeta hårdare ledde de minskade fettnivåerna och en 
reducerad användning av fett som energikälla till en sämre hjärtfunktion. 
Dessa möss hade även en sämre överlevnad efter hjärtinfarkt.  
 
Delarbete III. Här undersökte vi hur Perilipin2 (Plin2) var involverad i 
fettinlagring och hjärtfunktion efter hjärtinfarkt. Avsaknad av Plin2 i möss 
ledde paradoxalt nog till ökade nivåer av fett i hjärtat, trots att Plin2 har som 
funktion att skydda fettdroppar. Efter en hjärtinfarkt var hjärtfunktionen 
försämrad hos mössen som saknar Plin2, vilket visar att funktionen av Plin2 
är viktig efter en hjärtinfarkt.  
 
Från våra studier kan vi dra slutsatsen att reglering av fettinlagring i hjärtat 
påverkar hjärtfunktionen och utfallet efter en hjärtinfarkt. Förändrade 
fettnivåer i hjärtat efter en infarkt kan leda till sämre förmåga för hjärtat att 
återhämta sig. Forskning inom detta område kan därför leda till ny kunskap 
och på sikt resultera i utveckling av nya läkemedel mot hjärtkärlsjukdom. 
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AMPK AMP-activated protein kinase  
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ATP Adenosine triphosphate 
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The heart consists of four chambers that function as two separate pumps: (1) 
the right heart that pumps blood to the lungs and (2) the left heart that pumps 
blood to the systemic circulation. The cardiac cycle consists of diastole, the 
period of relaxation in which the heart is filled with blood, and systole, the 
contraction of the heart. During diastole, the deoxygenated blood from the 
systemic circulation flows through the inferior and superior vena cava to the 
right ventricle through the right atrium. Simultaneously, the oxygenated 
blood from the pulmonary circuit flows through the pulmonary veins into the 
left ventricle through the left atria. About 80 percent of the blood flows 
directly through the atria to the ventricles, and only the remaining 20 percent 
is delivered by contraction of the atria. The ventricles contracts shortly after 
the atrial contraction. The right ventricle ejects blood through the pulmonary 
arteries to the lungs and the left ventricle delivers blood to the peripheral 
organs through the aorta. The blood is prevented from flowing backwards by 
the atrioventricular valves (the tricuspid and mitral valves) and the semilunar 
valves (the aortic and pulmonary artery valves).
1
 
 
In the human heart, the left ventricle is filled to approximately 110-120 ml 
during diastole. This is called the end-diastolic volume. During contraction, 
the volume (about 70 ml) that is pumped out of the heart is called stroke 
volume. Thus, a volume of about 40 to 50 ml is remained in the ventricle and 
is referred to as the end-systolic volume. The ejection fraction is the fraction 
of the end-diastolic volume that is ejected from the heart and is around 60 % 
in a healthy heart. However, during physiological stress, such as exercise, the 
heart can the dramatically increase the cardiac output (the amount of blood 
ejected into the circulatory system in a minute). The major elements of this 
regulation are (1) the Frank-Starling mechanism and (2) the autonomic 
nervous system.
1
 The Frank-Starling mechanism is the intrinsic ability of the 
heart to adapt to increased venous return. The greater the heart muscle is 
stretched during filling, the stronger is the force of contraction. Thus, the 
heart ejects venous blood that is returned to the heart within physiological 
limits.
1, 2
 The autonomic nervous system of the heart consists of two 
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branches, the sympathetic and the parasympathetic systems. These systems 
work in a finely tuned but opposite fashion.
3
 Sympathetic stimulation can 
increase cardiac output by 100 percent, whereas strong parasympathetic 
stimulation can lower the heartbeat to 20–40 beats per minute.1     
 
The human heart is supplied with blood by coronary arteries; the blood 
within the ventricles only supplies the 100 µm of the inner endocardial 
surface. Two large epicardial arteries originate from the root of the aorta: the 
right coronary artery and the left coronary artery. The left coronary artery is 
branched into the left anterior descending artery (LAD) and circumflex 
artery, and they supply mainly the left atrium and ventricle, and the 
interventricular septum. The right coronary artery supplies most of the right 
side of the heart and parts of the left ventricle and septum. The coronary 
venous blood returns to the right atrium through the coronary sinus and 
anterior cardiac veins.
1,
 
4
     
 
Myocardial ischemia and ischemic heart disease are leading causes of death 
in the industrialized world. Life style factors in the Western societies such as 
high calorie food intake and minimal physical activity aggravates the risk of 
developing atherosclerosis and subsequent ischemic heart disease.
5
 
Myocardial infarction occurs when the blood flow supplying the heart muscle 
is blocked, resulting in necrosis of parts of the myocardium. The most 
common cause is the rupture of an atherosclerotic plaque in one of the 
coronary arteries. Early mortal complications following a myocardial 
infarction are cardiogenic shock, cardiac rupture and arrhythmia. Further, the 
loss of contractile myocardium and the subsequent reduced pump function 
promotes development of chronic heart failure.
1, 6, 7
  
 
An early reperfusion of blood flow to the injured myocardium reduces the 
infarct size and thereby improves the clinical outcome after a myocardial 
infarction. Thrombolytic therapy and percutaneous coronary intervention 
(widening of the stenotic coronary artery by balloon inflation) are the most 
used methods in clinic to restore blood flow following a myocardial 
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infarction.
8
 However, the reperfusion of the affected myocardium 
paradoxically also attenuates injury. Several mechanisms have been proposed 
to mediate the damage induced by the reperfusion, such as inflammation, 
increased radical oxygen species (ROS), increased levels of intracellular Ca
2+
 
and the reduction of oxidative phosphorylation.
8, 9
  
 
Profound morphologic and histological changes of infarcted myocardial 
tissue occur during and after a myocardial infarction. The lack of oxygen in 
the affected area leads to a rapid loss of cardiomyocytes. The cell death 
triggers inflammatory signals that recruits neutrophils and macrophages to 
the infarction. These inflammatory cells degrade the collagen framework 
surrounding the cardiomyocytes and aid the clearance of necrotic cells and 
their debris. The collagen structure is virtually vanished within the first week 
after the infarction. At this early time point, the ventricle wall is weakened 
and therefore susceptible to rupture. Approximately five days after the 
infarction, macrophages and endothelial cells promote angiogenesis and 
supply the new forming tissue with blood. Furthermore, myofibroblasts start 
to synthesize collagen which strengthens the ventricle wall. After several 
weeks, a solid scar has been formed with a stable cross-linked collagen 
structure. During this healing process, the left ventricle undergoes profound 
remodeling, involving myocyte hypertrophy and changes of the ventricular 
architecture to distribute the wall stress more evenly. A suboptimal 
remodeling of the heart can result in contractile dysfunction and development 
of heart failure. 
10, 11
 
12
 
 
The heart must contract continuously and have therefore a high energy 
demand. The mitochondria contribute to >95% of the ATP generated and 
occupies one third of the cardiomyocyte volume.
13
 The heart has a relatively 
small content of ATP and a fast hydrolysis resulting in a complete turnover 
of the pool every 10 s. In order to generate the high rate of ATP and sustain 
the contractility, the heart is flexible and can use all energy substrates 
including lipids, carbohydrates, amino acids and ketone bodies. However, 
lipids are the predominantly used energy substrate and 50-70% of the ATP is 
generated from fatty acid β-oxidation.14, 15 
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Lipids have a low solubility in plasma and are therefore supplied to the heart 
either as free fatty acids bound to albumin or as triglycerides and cholesteryl 
ester transported in lipoproteins.
16
  
 
To provide energy to the heart and other peripheral tissues, triglycerides 
stored in the adipose tissue are hydrolyzed into fatty acids and released into 
the circulation. Once leaving the adipocytes, the fatty acids are ionized and 
bind to the plasma protein albumin.
1, 17
 Normal concentrations of free fatty 
acids in the plasma vary between 0.2 and 0.6 mM. However, conditions such 
as fasting, poorly controlled diabetes and severe stress results in highly 
elevated levels of circulating free fatty acids.
18
  
 
Lipoproteins consist of a core of triglycerides and cholesteryl esters 
surrounded by a monolayer of amphipathic phospholipids with embedded 
apolipoproteins. There are several classes of apolipoproteins that, among 
many functions, can act as ligands for cell-surface receptors. Circulating 
chylomicrons transport dietary lipids absorbed by the intestine. The 
triglycerides in this lipoprotein are hydrolyzed in peripheral tissues, and the 
resulting remnant chylomicron is then removed from the circulation by the 
liver. Very low density lipoprotein (VLDL) is the principal transporter of 
endogenous triglycerides.  VLDL is secreted by the liver and has a high 
proportion of triglycerides but also contains cholesteryl esters. The 
triglycerides in the VLDL are hydrolyzed by the heart, adipose tissue and 
other peripheral tissues. As the triglycerides are removed, VLDL is 
subsequently transformed into intermediate density lipoprotein (IDL) and 
after that, low density lipoprotein (LDL). Hence, these lipoproteins contain 
larger proportions of cholesteryl esters and proteins and smaller proportion of 
triglycerides and phospholipids.
1
         
Triglyceride rich lipoproteins such as chylomicrons and VLDL provide the 
heart with triglycerides. To enable the uptake of triglycerides into the 
cardiomyocyte, the triglycerides are hydrolyzed into fatty acids by 
lipoprotein lipase (LPL) located at the endothelial wall.
14, 19
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After being dissociated from albumin or hydrolyzed from triglycerides in 
lipoproteins, the fatty acids are transferred from the microvascular 
compartment through the capillary endothelium and the interstitial 
compartment to the sarcolemmal membrane of the cardiomycocyte.
14
 Fatty 
acid uptake into the cardiomyocyte is facilitated either by passive diffusion or 
by protein-mediated uptake. The former alternative represents a non-saturable 
low affinity process where the fatty acids flip-flop through the membrane.
20
 
However, the predominant uptake of fatty acids are mediated via a family of 
transporters: fatty acid translocase (FAT/CD36) (hereafter referred to as 
CD36), plasma membrane fatty acid–binding protein (FABPpm), and fatty 
acid transport protein 1 (FATP1).
21, 22
 CD36 is the predominately studied 
fatty acid carrier and it has been shown that 50-60 % of the fatty acid uptake 
is mediated via CD36.
23
 Further, CD36 is able to relocate from the 
endosomes to the sarcolemmal membrane to increase fatty acid uptake in 
response to insulin, contraction, and AMP-activated protein kinase (AMPK) 
activation. Thus, CD36 has a key regulatory function of fatty acid uptake.
14
    
 
The VLDL receptor (VLDLr) has also been implicated to play a role in 
triglyceride uptake.
24
 The VLDLr is most abundant in the heart, but is also 
expressed in other tissues including skeletal muscle, adipose tissue and 
brain.
25
 VLDLr mediates lipid uptake either by endocytosis of lipoproteins or 
by cooperation with LPL.
26,
 
27
    
β
Fatty acid β-oxidation is the catalytic process by which fatty acids are broken 
down in the mitochondria to produce ATP. After uptake of fatty acids into 
the cytoplasm of the cardiomyocyte, fatty acyl-CoA synthetase (FACS) 
activates the fatty acids by adding a CoA moiety (figure 1). The two main 
pathways of these fatty acid-CoAs are (1) delivery to the mitochondria for 
oxidation or (2) esterification to triglycerides for temporary storage in the 
triglyceride pool in cytosolic lipid droplets.
28
 Storage of lipids in cardiac lipid 
droplets will be described in more detail in section “Lipid storage”.  
 
In contrast to short- and medium-chain fatty acids, long-chain fatty acids, 
which constitute the major fraction of the fatty acids, cannot simply diffuse 
through the mitochondrial membranes. Therefore, long-chain fatty acids are 
converted to long chain acylcarnitine by carnitine palmitoyltransferase 1 
(CPT1) located at the outer mitochondrial membrane. The fatty acids are 
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shuttled through the inner mitochondrial membrane by carnitine-acylcarnitine 
translocase (CAT), following by conversion back to acyl-CoA by CPT2.
29
 
The entrance of fatty acids into the mitochondria can be regulated by 
allosteric inhibition of CPT1 by malonyl-CoA.
14
    
 
After the entrance into the mitochondrial matrix, β-oxidation of fatty acids 
occurs by cleaving two carbons of the fatty acid each cycle, forming acetyl-
CoA as well as NADH and FADH2. Each cycle produces theoretically 5 ATP 
from the generation of NADH and FADH2. However, the entrance of acetyl-
CoA into the TCA cycle yields additionally 12 ATP.
30
 
The TCA cycle (also referred as citric acid cycle or Krebs cycle) is the final 
common pathway for the oxidation of fuel molecules such as fatty acids, 
glucose and amino acids. The cycle is also an important source of precursors, 
e.g. for amino acids and nucleotide bases. In the first step, acetyl-CoA, 
derived from glucose or fatty acids, combines with oxaloacetate to form 
citrate. After a sequence of chemical reactions oxaloacetate is regenerated, 
allowing the cycle to continue. The tricarboxylic acid (TCA) cycle generates 
the reducing equivalents NADH and FADH2 and also CO2
 
as a byproduct. 
NADH and FADH2 deliver electrons to the electron transport chain, resulting 
in ATP formation by oxidative phosphorylation.
1
   
 
Glucose uptake into cardiomyocytes is mediated by glucose transporters. 
GLUT4 and GLUT1 is the predominantly glucose transporters expressed in 
the heart. In the adult heart, GLUT4 is the isoform responsible for the 
majority of the myocardial glucose uptake. However, there are a variety of 
pathophysiological circumstances, for instance ischemia, in which GLUT1 
expression is induced in the heart.
31
 Further, GLUT3 and GLUT5 may also 
be upregulated during ischemia.
32
 In order to increase the glucose uptake, 
GLUT4 is recruited to the sarcolemmal membrane from intracellular vesicles 
in response to insulin signaling, high work load or ischemia.
33
  
 
After uptake, glucose is rapidly converted to glucose-6-phosphate (G6P). The 
negative charge prevents G6P from diffusing out of the cell, which lacks 
transporters for this substrate. G6P can enter several metabolic pathways of 
which glycolysis is the predominant one. The glycolytic pathway converts 
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G6P into pyruvate and generates two ATP for each molecule of glucose. 
Pyruvate can either (1) be converted to lactate in the cytosol in an anaerobic 
process or (2) be shuttled into the mitochondrial matrix to be transformed to 
acetyl-CoA by the pyruvate dehydrogenase (PDH) complex for subsequent 
oxidation in the TCA cycle (figure 1).
34
  
 
 
Figure 1. Schematic overview of fatty acid β-oxidation and glucose oxidation in the 
cardiomyocyte. CD36, cluster of differentiation 36; FATBPpm, plasma membrane 
fatty acid-binding protein; FATP, fatty acid transport protein; FACS,  fatty acyl coA 
synthase; CPT, carnitine palmitoyltransferase; CAT, carnitine-acylcarnitine 
translocase; GLUT, glucose transporter; PDH, pyruvate dehydrogenase.      
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Cholesterol is important for the function and fluidity of the plasma 
membrane, and is also a precursor molecule in several biochemical pathways 
in liver and adrenal gland.
35
 The heart is among the tissues with the lowest de 
novo cholesterol biosynthesis.
36
 Thus, circulating lipoproteins is important 
for supplying heart with cholesteryl esters. 
 
Cholesteryl ester delivery occurs via endocytosis of LDL via LDL receptor 
(LDLr) mediated uptake. LDLr is located on the cell surface and the 
internalized lipoprotein is delivered to the lysosome where the cholesteryl 
esters are hydrolyzed. The liberated cholesterol is either used by the cell or 
stored as cholesteryl esters in lipid droplets. The LDLr are recycled back to 
the plasma membrane.
35
 The LDLr belongs to a family of lipoproteins 
receptors: LDLr gene family. Two other members of the family are VLDLr 
and low density lipoprotein receptor-related protein 1 (LRP1).
37
  
 
In addition, selective uptake of cholesteryl esters in the core of lipoproteins 
has been reported in the heart and arterial wall.
38
 
39
 LPL increased selective 
uptake of LDL cholesterol in LDLr negative human fibroblasts and CHO 
cells,
40
 suggesting a cholesteryl ester uptake independent of LDLr.  
 
In the ischemic heart, the coronary blood flow is inadequate to supply the 
myocardium resulting in a mismatch between the oxygen demand and the 
oxygen supply. The well-perfused heart has high oxygen consumption due to 
its high energy demand. Thus, low oxygen availability drives the heart into 
major alterations of the energy metabolism. The myocardial ischemia results 
in a decreased oxidative metabolism and a subsequent decline in ATP 
production (figure 2).  
 
The extent of the reduction in glucose and fatty acid oxidation is dependent 
of the severity of the ischemia. During severe ischemia caused by a 
myocardial infarction, the oxygen demanding oxidative metabolism is 
dramatically reduced and the major source of ATP is anaerobic glycolysis: 
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the conversion of pyruvate to lactate via lactate dehydrogenase (LDH). 
Hence, anaerobic glycolysis is uncoupled from the glucose oxidation and 
thereby provides a limited amount of ATP.  Further, the accumulation of 
deleterious byproducts of glycolysis, lactate and H
+
, result in an increased 
expenditure of ATP to reestablishing of ionic homeostasis. Altogether, the 
reduction in ATP production results in a reduction in cardiac function and 
efficiency.
14,
 
41
  
 
Hypoxia-inducible factor (HIF) and 5′-AMP-activated protein kinase 
(AMPK) are two important components in the cellular response to 
myocardial ischemia. The transcription factor HIF1α is degraded during 
normal oxygen concentration. However, during low oxygen availability 
HIF1α escapes degradation and promotes transcription of numerous of genes 
including GLUT1 and LDH. Thus, HIF1α activates genes involved in 
oxygen-independent ATP synthesis.
42
 AMPK is highly activated during 
ischemia by increased levels of AMP, an indicator of compromised cellular 
energy availability. AMPK can be considered to be a fuel gauge, responsible 
for the activation a number of energy-producing metabolic pathways as well 
as inhibiting energy-consuming pathways. Thus, AMPK activation results in 
an increase in glucose utilization, e.g. by promoting the translocation of 
GLUT4 to the sarcolemma and by stimulation of glycolysis via 
phosphorylation of phosphofructokinase 2. Further, AMPK activation also 
stimulates β-oxidation e.g. by reducing the malonyl-CoA levels. Hence, 
during mild ischemia β-oxidation remains the major source of the residual 
oxidative metabolism.
41, 43
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Figure 2. Schematic figure of metabolic alterations in the ischemic 
cardiomyocyte. LDH, lactate dehydrogenase.  
 
 
Reduced oxygen availability promotes myocardial accumulation of neutral 
lipids, such as triglycerides and cholesterol esters.
24,
 
44,
 
45
 Due to the reduced 
fatty acid oxidation during ischemia, fatty acids are not used for energy 
production but are instead converted to triglycerides that accumulate in the 
cell. However, lipid uptake has also been reported to be increased in the 
ischemic heart contributing to the lipid accumulation.
24
 During ischemic 
insult, plasma level of norepinephrine is elevated which promotes adipose 
tissue lipolysis. This results in increased concentration of circulating free 
fatty acids, thus, increases the delivery of fatty acids to the myocardium.
14, 46
 
In addition to increased availability of circulating fatty acids, cellular 
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response to hypoxia promoting lipid accumulation has been reported. 
Chabowski et al have demonstrated a hypoxia-induced translocation of fatty 
acid transporters CD36 and FABPpm to the sarcolemma resulting in an 
increased lipid accumulation in hypoxic isolated hearts.
47
 Further, increased 
cardiac lipid uptake mediated via HIF1α induced up-regulation of VLDL 
receptor
24
 and LRP1
45
 has been described.         
 
The issue whether lipid accumulation is detrimental for the ischemic heart or 
not is complex. Lipid accumulation in the heart has been associated with 
cardiac dysfunction, suggesting a detrimental role of excessive lipids in the 
heart.
48,
 
49
 On the other hand, storage of lipids in the form of inert 
triglycerides has been postulated to be protective to heart function.
50,
 
51
 Thus, 
sequestration of fatty acids in the triglyceride pool potentially protects the 
cell from toxic fatty acid metabolites, such as fatty acids, and ceramides. 
These lipids are regarded as bioactive lipids with cell signaling functions. An 
excess of free fatty acids have been reported to promote increased oxidative 
stress and apoptosis.
52
 Further, increased availability of saturated fatty acids 
appears to be the primary trigger of synthesis of ceramides. Ceramides are 
synthesized either de novo from serine and palmitate or by breakdown from 
sphingomyelin.
53
 Increased levels of ceramides are associated with cellular 
apoptosis and ROS production.
54, 55,
 
56
 Further, ceramide reduction in LPL
GPI 
mice, a transgenic mouse model displaying increased levels of ceramides, 
was associated with improved cardiac function.
57
  
 
Interference with protein folding or any of the major functions of ER results 
in ER stress. This leads to activation of the unfolded protein response (UPR), 
a signaling cascade from ER to the nucleus that induces a comprehensive 
gene expression program. The UPR triggers an adaptive response in order to 
reestablish ER homeostasis by reducing the protein synthesis, upregulating 
expression of ER resident chaperones as well as degrading misfolded 
proteins.
58
 During ischemia, there are significant nutrient and oxygen 
starvation which lead to the induction of ER stress. For example, the activity 
of protein disulfide isomerase (PDI) is dependent on molecular oxygen. 
During hypoxia or ischemia, disulfide bonds are not formed resulting in 
accumulation of misfolded proteins and subsequent ER stress.
59
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The ER molecular chaperone BiP/GRP78 protein is involved in sensing 
misfolded protein accumulation in the ER and are responsible for the 
initiating the response to ER stress in combination with three ER integral 
membrane protein: dsRNA-activated protein kinase–like ER kinase (PERK), 
inositol-requiring kinase 1 (IRE1) and activating transcription factor 6 
(ATF6). However, if the ER stress is severe or prolonged, the UPR may lead 
to apoptosis. This is promoted by transcriptional induction of C/EBP 
homologous protein (CHOP), the caspase 12-dependent pathway and 
activation of the c-Jun NH2-terminal kinase (JNK)-dependent pathway.
59,
 
60
  
 
Triglycerides and cholesteryl esters are hydrophobic lipids and thus insoluble 
in the cytosol. Hence, these lipids are stored in the core of so called lipid 
droplets. The lipid core is surrounded by a monolayer of amphipathic lipids, 
such as phospholipids and unesterified cholesterol (figure 3). The lipid 
droplet was long considered to be a passive storage pool of lipids, but is now 
recognized as a dynamic organelle that is involved in numerous of cellular 
processes. Thus, the lipid droplets are coated with a large number of proteins 
that are critical for the formation, trafficking and stability of the lipid 
droplet.
61,
 
62
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic view of 
the lipid droplet.  
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The loading of hydrophobic lipids in a water free phase provides the most 
efficient form of energy storage. The lipid droplets are intracellular lipid 
reservoirs providing lipids for energy metabolism, membrane synthesis and 
steroid synthesis.
63
 Nearly all cell types have the ability to generate lipid 
droplets when there is a surplus of fatty acids to be subsequently used as 
source of energy when conditions are sparse. The number and size of lipid 
droplets differ between different cell types, with sizes ranging from 100 nm 
to 100 µm. The lipid droplets in white adipocytes are large, with diameters up 
to 100 μm, and fill almost the entire cytoplasm.64  
 
Lipid droplets are formed de novo from the ER. The exact mechanism of the 
lipid droplet formation is poorly understood. One model suggests that neutral 
lipids are synthesized between the two leaflets of the ER membrane. The 
formed lipids are highly hydrophobic and have a limited solubility in the 
membrane and therefore form a lens structure that is the core of the lipid 
droplets. The mature lipid droplet is then thought to bud from the ER 
membrane to form an independent organelle with a monolayer of 
phospholipids.
65, 66
  
 
The storage capability of lipids is increased by formation of new lipid 
droplets and by growth of existing droplets.
64
 Lipid droplet has been 
proposed to grow by de novo triglyceride synthesis directly in the droplet. 
DGAT2 catalyzes the final step of triglyceride synthesis and have been 
associated to the lipid droplet in conditions of oleate loading.
67
 In addition, 
the increase in surface area of the lipid droplet during expansion requires 
large increases of the phospholipid content. CTP:phosphocholine 
cytidylyltransferase (CCT), catalyze the rate-limiting step in PC biosynthesis 
and have been shown to be activated by binding to lipid droplets.
68,
 
69
   
 
When energy is required, the triglycerides in the lipid droplet are hydrolyzed 
to generate fatty acids.
70
 Triglyceride lipolysis is a three-step process where 
adipose triglyceride lipase (ATGL) selectively performs the first and rate-
limiting step generating diglycerides and non-esterified fatty acids.
71
 
Hormone-sensitive lipase (HSL) is rate-limiting for diglyceride hydrolysis.
72
 
Finally, monoglyceride lipase efficiently cleaves monoglyceride into glycerol 
and non-esterified fatty acids.
73
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Analyses of the lipid droplet proteome have revealed a large number of lipid 
droplet–associated proteins. However, many of those are most possibly not 
genuine associated proteins but are artifacts originating from the purification 
process.
74
 One group of proteins associated with the lipid droplets are the Rab 
proteins, which are GTPases involved in trafficking event.
66
 Rab18 have been 
suggested to localize to lipolytically active lipid droplets and mediate an 
increased association with the ER.
75
 However, the best characterized and 
most abundant proteins on the lipid droplets are the perilipins, a family of 
five related proteins.
74
    
 
The family of perilipins has undergone a change in nomenclature and was 
formerly known as the PAT family, named after the three first discovered 
perilipins: perilipin, ADRP, TIP47. The mammalian genome encodes five so 
far discovered perilipin (Plin) genes: Plin1-5. Plin1, 2, 3, and 5 share a highly 
conserved N-terminal domain and an 11-mer repeating helical organization. 
Plin4 is the most divergent member of the perilipin family with a highly 
expanded 11-mer repeat region.
76,
 
77
 
 
The perilipins appear to play an important role in regulating storage of lipids 
and to protect lipid droplets from unregulated hydrolysis. The perilipins share 
the ability of binding to lipid droplets, but display different tissue and 
subcellular localization. This suggests that each perilipin has a unique role in 
the lipid dynamics. Plin1 and 2 are located exclusively on lipid droplets, and 
Plin2 is rapidly degraded in absence of lipid droplets. In contrast, Plin3, 4 and 
5 are stable in absence of LDs and have been shown to translocate from a 
cytosolic pool to nascent lipid droplet in response to fatty acid 
supplementation or other conditions promoting lipid droplet formation.
78, 79,
 
80
  
 
Plin1 is primarily expressed in white adipose tissue (WAT), brown adipose 
tissue (BAT), and steroidogenic tissue.
81
 Early studies have identified Plin1 
as a major regulator of adipocyte lipolysis.
82
 Under basal lipolytic conditions, 
the lipases ATGL and HSL are cytosolic whereas Plin1 is located on the lipid 
droplet in association with comparative gene identification-58 (CGI-58), the 
co-activator of ATGL. This prevents CGI-58 from binding to ATGL and to 
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facilitate ATGL-mediated triglyceride hydrolase activity. Thus, the lipolysis 
is maintained at low rates. However, upon β-adrenergic stimulation, Plin1 
and HSL are phosphorylated by protein kinase A (PKA). This allows (1) 
CGI-58 to dissociate from Plin1 and recruit ATGL and (2) HSL to translocate 
to the lipid droplet. Thus, during basal conditions Plin1 functions as a barrier 
to lipases, whereas Plin1 participates in their recruitment after β-adrenergic 
stimulation.
83,
 
84
 
 
Plin2 is ubiquitously expressed in the body. Overexpression of Plin2 results 
in increased formation of lipid droplets.
85,
 
86
 Phospholipids as well as 
triglycerides and cholesteryl esters are increased upon Plin2 overexpression, 
suggesting that Plin2 may play a role in increasing lipid droplet membrane 
size to support lipid droplet expansion.
87
 The stability of is Plin2 is mediated 
by lipid droplets and the protein is degraded by the proteasome in the absence 
of neutral lipids.
88, 89
 
 
In WAT deficient in Plin1, Plin2 becomes the major protein coating lipid 
droplets. In the Plin1
−/−
 adipocytes, the basal lipolysis is elevated compared 
to WT, but the stimulated lipolysis is decreased.
90, 91
 This suggests that 
unphosphorylated Plin1 is more protective to lipases than Plin2, which in turn 
is more protective than phosphorylated Plin1.  
 
Plin2 is the major protein coating lipid droplets in the liver. Deletion of Plin2 
protects against lipid droplet accumulation and chronic inflammation in liver 
in mice on a high-fat diet.
92,
 
93
 Further, Plin2
–/–
 lacking leptin have improved 
systemic glucose and lipid homeostasis compared to leptin deficient controls. 
As expected, muscle-specific PLIN2 overexpression resulted in increased 
lipid droplet accumulation. Interestingly, PLIN2 overexpression improved 
skeletal muscle insulin sensitivity.
94
 
 
In humans, a missense polymorphism of Plin2, Ser251Pro, resulting in 
structural changes in the protein has been described. The polymorphism was 
associated with increased lipid accumulation and decreased lipolysis in cells, 
and carriers of the minor Pro251 allele had decreased circulating triglycerides 
and VLDL concentrations.
95
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Similar to Plin2, Plin3 is widely expressed in the body and also shares the 
highest sequence homology with Plin2 of all perilipins. In addition to its role 
in lipid droplet biogenesis, Plin3 was reported to be involved in the 
intracellular transport of mannose 6-phosphate receptors between the trans-
Golgi and endosomes.
96
 Structural analysis of the protein have indicated the 
existence of two distinct ‘functional modules’, which may explain the dual 
function of Plin3.
97, 87
 Although Plin2 is the dominating perilipin in the 
hepatocytes, depletion of Plin3 has been reported to suppress hepatic 
steatosis.
98
 
 
Plin4 have a divergent amino acid structure compared to Plin2, 3 and 5 and 
also show a limited tissue distribution. Plin4 is mainly found in white adipose 
tissue and are expressed in low levels in heart and skeletal muscle. Although 
Plin4 and Plin1 both are expressed in adipocytes, they are located in different 
lipid droplet pools. Plin4 have been shown to translocate to nascent LDs 
upon lipid loading in adipocyte, thus participating in the early formation of 
lipid droplets.
99
 However, Plin4 deficiency in mice resulted in an unperturbed 
adipocyte differentiation and development. Interestingly, the Plin4
−/− 
had a 
dramatically reduced triglyceride content in the heart. This was associated 
with a reduction in Plin5, whose gene is located immediately upstream of 
Plin4. It remains to be investigated whether the targeting of Plin4 had an 
impact on the transcriptional action at the Plin5 locus.
91,100
  
 
Plin5 is predominantly expressed in tissues with high mitochondrial β-
oxidation such as the heart, skeletal muscle, liver and BAT. Plin5 expression 
is increased under conditions that promote fatty acid elevation, including 
fasting and exercise.
101
 The Plin5 gene has been reported to be 
transcriptionally regulated by members of the peroxisomal proliferator-
activated receptors (PPARs). PPARα is expressed in fatty acid metabolizing 
tissues and is activated under conditions of energy deprivation. Cardiac 
expression of Plin5 can be induced by PPARα agonists.80, 102, 103 However, 
although PPARα–/– mice displays reduced levels of Plin5 in the basal state, 
the expression of Plin5 was induced by fasting, suggesting additional 
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regulatory control of Plin5.
104
 One additional regulator may be PPARβ/δ, 
which has been shown to induce Plin5 in skeletal muscle.
105
 
  
Similar to other perilipins, Plin5 prevents uncontrolled lipolysis of lipid 
droplets. ATGL mediated lipolysis was shown to be inhibited in lipid 
droplets in cells either derived from cardiac tissue of mice overexpressing 
cardiac Plin5 or from COS-7 cells overexpressing recombinant Plin5.
106
 Plin5 
has been shown to interact with ATGL, HSL as well as CGI-58. 
107, 108,
 
109
 In 
contrast to Plin1-regulated lipolysis, the exact mechanism is not fully 
understood. However, the binding of Plin5 to ATGL or CGI-58 has been 
proposed to prevent their interaction and thereby reduce lipolysis.
101
 Further, 
Plin5 is a substrate for PKA phosphorylation,
107
 and PKA treatment have 
been reported to stimulate fatty acid release in vitro from lipid droplets 
enriched with Plin5.
110
 Altogether, this suggests that Plin5 functions as a 
barrier towards lipolysis of the lipid droplet in the basal state. Possibly, in 
response to β-adrenergic stimulation, PKA unlocks the Plin5 barrier function 
and thereby promotes hydrolysis of the triglycerides. 
  
Global Plin5
−/−
 mice have normal growth rates, organ weights, and lean and 
fat masses compared with their wild type littermates.
111,
 
112
 Deletion of Plin5 
resulted in reduced levels of triglycerides in the heart and red oxidative 
muscle.
111
 Overexpressing Plin5 in skeletal muscle by gene electrophoresis 
led to an increased triglyceride pool and lipid droplet size, supporting the role 
of Plin5 in protection of lipid droplets.
113
  
 
Close physical and functional interaction between lipid droplets and 
mitochondria is crucial for the function of highly oxidative tissues with a 
fluctuating energy demand.  A mitochondrial recruitment domain positioned 
in the C terminal of Plin5 has been identified and overexpression of Plin5 in 
fibroblasts mediates a close association of lipid droplets and mitochondria.
114
 
Also, mitochondrial and Plin5 association are increased after electrically 
induced contraction in rat skeletal muscle together with a reduction in the 
triglyceride pool.
115
 Thus, this suggests that Plin5 facilitates the transfer of 
fatty acids from lipid droplets to mitochondria. 
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The overall aim of this study was to investigate cardiac lipid accumulation 
and the consequences of altered lipid storage and metabolism following 
myocardial ischemia.   
Specific aims 
1) To investigate the derangements of cardiac lipid 
metabolism in a porcine model of ischemia/reperfusion.  
 
2) To investigate the role of the lipid droplet protein Plin5 in 
myocardial lipid dynamics, cardiac function, and outcome 
after myocardial ischemia. 
 
3) To investigate the role of the lipid droplet protein Plin2 in 
myocardial lipid metabolism, heart function and outcome 
after an induced myocardial infarction. 
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In this section, considerations regarding selected methods in human subjects, 
animal models and cell culture are discussed. A more detailed descriptions of 
all methods and material and are included in the enclosed papers.   
 
To study genetic variance of PLIN5 gene, 468 patients with clinically 
suspected coronary artery disease were recruited. Four SNPs in PLIN5 were 
successfully genotyped in 466 of 468 patients using TaqMan assays. The four 
SNPs was selected based on an expected minor allele frequency >5%, no or 
weak linkage disequilibrium, and presumed potential effects on protein 
function (mediated by amino acid change) and protein concentration 
(mediated by mRNA stability and splicing pattern). The heart function of the 
patients was examined with myocardial perfusion scintigraphy and standard 
and stress echocardiography.  
 
Myocardial perfusion scintigraphy is used to detect and localize perfusion 
defects. Myocardial perfusion images are acquired by injecting a radiotracer 
intravenously. The isotope is extracted from the blood by viable myocytes 
and retained there for a period of time. A gamma camera captures the 
photons and converts the information into digital data reflecting the 
magnitude of tracer uptake and location of the emission.
116
 The resulting 
myocardial perfusion images show the presence, location, extent and severity 
of myocardial perfusion abnormalities. By comparing images acquired during 
rest and stress the defects can be determined to be either (1) reversible, 
reflecting stress-induced ischemia, or (2) irreversible, implying myocardial 
infarction. Patients with normal myocardial perfusion scans have a low rate 
(<1%) of future annual death or non-fatal myocardial infarction.
117
 However, 
the greater the extent and severity of ischemic perfusion abnormalities the 
larger is the risk of adverse events.
118
  
To assess abnormalities in wall motion of the heart, stress echocardiography 
can be used. 2D echocardiography images are obtained at rest and during 
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physical or pharmacological stress. The analysis and scoring of the regional 
wall motion are usually done using a 17 segment model of the left ventricle. 
In a normal response, a segment is normokinetic at rest and normal or 
hyperkinetic during stress. However, during ischemia the segment is normal 
at rest but displays an abnormal movement during stress. An infarcted area 
has abnormal movement both during rest and stress. Reduction in contractile 
function reflected by abnormal wall motion appears immediately during acute 
ischemia and infarction.
119
 
 
 
A global Plin5
–/–
 mice was kindly provided by K.T Dalen. Briefly, using 
homologous recombination, exons 4 to 6 of the Plin5 gene were replaced 
with a hygromycin selection cassette flanked by FRT5-sites and restriction 
sites. The Plin5-KO targeting vector was electroporated into embryonic stem 
(ES) cells and positive ES clones were injected into C57/Bl6 blastocysts. The 
obtained chimera was mated with a female 129/SvEv to confirm germ line in 
a pure 129/SvEv background. The mice were then backcrossed to a 
C57BL/6JBomTac background. Heterozygote breeding was used and WT 
littermates (Plin5
+/+
) were used as controls. 
 
The hygromycin selection cassette was not removed from the mutated PLIN5 
gene in the Plin5
–/–
 mice. A retained selection cassette has previously been 
reported to influence the gene expression.
120, 121
 However, in a knockout 
model a truncated protein, or more often, no protein is produced. Thus, the 
retained selection cassette is of less importance in our Plin5
–/–
 model.  
 
Plin5 is globally deficient in our mouse model. The protein is expressed in 
highly oxidative tissues, such as the heart, liver and skeletal muscle. 
However, we are investigating the role of Plin5 in the heart. The Plin5 
deficiency in the liver could influence the hepatic secretion of glucose and 
lipids into the circulation and hence affect the concentration of substrates 
available to the heart. However, when feeding the Plin5
–/–
 mice a regular 
chow diet, the systemic levels of triglycerides, cholesterol, glucose and 
insulin did not differ between the WT and Plin5
–/–
 mice. Thus, our 
experiments were conducted in mice fed a regular chow diet.  
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Whole-body Plin2
–/–
 mice was kindly provided by K.T Dalen. To generate 
the Plin2
–/–
 mice, the exons 4-6 were deleted using Cre-LoxP recombination. 
The mice were fed chow diet ad libitum. The mice were fasted 4 hours prior 
to experiments. Circulating levels of glucose, insulin, cholesterol and 
triglycerides did not differ between WT and Plin2
–/–
 mice.     
 
There are previously two Plin2 mutant models characterized. In the first 
model, exons 2 and 3 were deleted in the PLIN2 gene resulting in the absence 
of a full length Plin2 protein. In this Plin2
(Δ2,3/ Δ2,3) 
mouse, a bioactive large C-
terminal variant of Plin2 was shown to be expressed in some tissues, however 
not in the liver.
91, 122
 In the second Plin2 knockout model, Plin2
(Δ5/ Δ5)
, exon 5 
was deleted and the mice had no detectable expression of the Plin2 protein. In 
both models, the Plin2 deficiency resulted in reduced hepatic lipid droplets 
following high fat diet. In agreement with our Plin2
–/–
 
 
model, the plasma 
levels of glucose, insulin, cholesterol and triglycerides was unchanged in the 
Plin2
(Δ2,3/ Δ2,3)
 mice on a chow diet.
93
 In contrast, when fed a high fat diet, the 
Plin2
(Δ5/ Δ5) 
mice had reduced levels of insulin, fatty acids and triglycerides.
92
 
 
Female pigs of a mixed Swedish, Pigham and Yorkshire race were used for 
an ischemia/reperfusion model. They were 3–4 months old and weighed 38–
46 kg. The pigs were bred in Swedish farms and brought to the animal 
laboratory one week prior to the procedure. 
 
 
To induce ischemia/reperfusion in pig, an angioplasty balloon was inflated in 
the left anterior descending artery distal to the second diagonal branch. After 
40 min of occlusion, the balloon was deflated and the heart was reperfused. 
After 4 hours of reperfusion, the chest was opened and an angioplasty balloon 
was inflated at the same location as before. Evans blue was infused, followed 
by an injection of a lethal dose of potassium chloride.  
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The induction of myocardial infarction in mice is described in detail in the 
method section in Paper II. Briefly, an incision was made between the 4
th
 and 
5
th
 ribs to reveal the upper part of the anterior LV wall and the lower part of 
the left atrium. A myocardial infarction was induced by ligating the left 
anterior descending coronary artery immediately after the bifurcation of the 
left coronary artery. After verification of the infarction, the chest was closed.   
There are differences in our infarction models as the experimental procedure 
ought to be adjusted to the size and characteristics of the animal. The size of 
the pig makes it possible to perform a closed-chest protocol with an occlusion 
of the LAD with an inflated balloon. This resembles more closely the clinical 
situation were the artery are occluded by a plaque in vessel and the risk of 
external damages when ligating the vessel is eliminated. Further, the size of 
the pig heart enables separation of the area at risk (AAR), infarct area (IA) 
and the non-ischemic control area. Hence, it is possible to analyze lipid 
accumulation and the gene expression in every separate area (control, AAR 
and IA) of the infarcted heart. Another crucial difference between the models 
is the presence of reperfusion in the pig infarction protocol. This resembles 
more closely the optimal clinical situation where a patient with a myocardial 
infarction is revascularized within a short period of time.  
 
The mouse is widely employed in studies of experimental myocardial 
infarction, in part because of the possibility of genetic manipulation. The 
mouse as a model has several other advantages, e.g. their small size and short 
life span makes them easy and less expensive to house. Further, in mice, the 
long-term remodeling of the heart and survival following a myocardial 
infarction can be studied.     
The rational for using a porcine model is the large homology with the human 
cardiovascular system. The heart of the pig is approximately the size of the 
human heart. More importantly, the coronary artery pattern and cardiac 
physiology in the pig heart is very similar to humans. Potential residual flow 
to ischemic tissue is an issue in animal models of myocardial infarction. 
Importantly, the low collateral circulation in pig resembles the human 
collateral flow during normal coronary conditions.
123-125
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The coronary arteries of the mouse are not characterized to the same degree 
as the human coronary vasculature. Mice have two major coronary arteries, 
both of which originate in or slightly above the aortic sinus. The left coronary 
artery generally crosses over the left ventricle and gives off variable 
branches.
126, 127
 A branch has been described as LAD in mice because of its 
similarity to the LAD in human. However, in humans the LAD supplies 
approximately the anterior aspect of the LV wall and the anterior two thirds 
of the septum. In mice, ligation of the LAD gives rise to infarction of the free 
wall of the LV extending to the apex whereas the septum is unaffected.
128
 
 
We have used the Langendorff model system in order to study the intrinsic 
metabolism of the heart. This system enables the study of an isolated heart 
without confounding effects of other organ systems and exocrine control. 
Briefly, the mouse aorta was cannulated and perfused in a Langendorff mode 
at a constant pressure of 70 mm Hg. Hearts were perfused with Krebs-
Henseleit buffer containing 11 mM glucose and 0.4 mM palmitate (bound to 
1% fatty-acid free bovine serum albumin), gassed with 95% O2 and 5% CO2. 
To measure functional changes during the perfusion protocol, a fluid-filled 
balloon was inserted into the left ventricle, inflated to achieve an end-
diastolic pressure of 5-10 mm Hg.  
 
In the Langendorff methodology, the heart is perfused by cannulating the 
aorta. The perfusion buffer is hence flowing in opposite direction compared 
to the physiological blood flow. This pressure causes the aortic valve to 
close, and the column of buffer in the aorta causes the filling of the coronary 
artery vasculature via the two coronary ostia in the aortic root. The perfusion 
buffer then flows through the vascular bed before being drained through the 
coronary sinus in the right atria. The effluent is ejected through the 
pulmonary artery and is allowed to drip from the heart. Thus, the ventricles 
are not filled with perfusion buffer.
129
 
 
The HL-1 cell line is a cardiac muscle cells line derived from the AT-1 
mouse atrial cardiomyocyte tumor lineage. The HL-1 cells contracts 
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spontaneously and can, in contrast to primary cardiomyocytes, be serially 
passaged. The HL-1 cell line has been extensively characterized, and has 
been shown to have a gene expression pattern similar to adult atrial 
myocytes.
130, 131
 The HL-1 cells was cultured in Claycomb medium 
supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 10 % fetal calf serum. Norepinephrine was added to the 
medium to enable the cells to contract.  
 
Plin5 is expressed in HL-1 in a very low extent. This is consistent with other 
cell lines, such as the murine myoblast cell line C2C12.
105
 For that reason, we 
have not used HL-1 cell line for studies regarding Plin5. However, the 
unphysiological expression of Plin5 might have an impact on the function 
and expression of Plin2 and other lipid droplet proteins. Thus, additional 
model systems, i.e. Plin2 deficient mice, are required to complement our 
studies on the function of Plin2.         
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In this paper, we investigated the derangements of cardiac lipid metabolism 
in a porcine model of ischemia/reperfusion.  
 
We investigated lipid accumulation in 7 pigs subjected to 40 min of ischemia 
followed by 4 h of reperfusion. The pig hearts was separated into the infarct 
area (IA) with irreversible injury and the area at risk (AAR) subjected to 
ischemia but with reversible injury. Non-ischemic biopsies from the lateral 
wall served as a control. Oil red O staining of cryosections from the heart 
biopsies showed an increase in lipid droplet accumulation in the AAR and 
IR. Interestingly, the triglyceride content was not altered in the ischemic 
areas whereas the cholesteryl ester content was highly increased. The VLDLr 
have previously shown to be up-regulated after an induced myocardial 
infarction in mice.
24
 We analyzed the expression of VLDLr and did not 
observe an increase in this receptor. However, the elevated cholesteryl ester 
concentration led us to examine the expression of LDLr and LRP1 and we 
found that the expression of these receptors was greatly increased.  Thus, our 
data indicates that LRP1 and LDLr mediate an increased uptake of 
cholesteryl esters in the porcine heart.  
  
Elevated levels of bioactive lipids such as ceramides have been reported to 
cause impaired heart function. When analyzing the ceramide content we 
found increased levels in the IA but interestingly not in the AAR, suggesting 
that reperfusion normalize levels of ceramides in the viable area. Ceramides 
are synthesized de novo or from sphingomyelin. However, we found that 
sphingomyelin levels were decreased in AAR as well as in IA compared with 
control tissue.  
 
Finally, we examined the inflammation and ER stress in our porcine model of 
ischemia/reperfusion. The cytokines IL-1b and IL-6 were dramatically 
increased in the AAR and the IA. Further, we found an increase in ER stress 
markers calnexin and GRP78 in the AAR and IA. Interestingly, the pro-
apoptopic marker CHOP was upregulated only in the AAR.  
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In conclusion, we found that ischemia/reperfusion promoted cholesteryl ester 
accumulation mediated by the LDLr and LPR1 in the porcine heart. Further, 
we found increased levels of inflammation and ER stress in the AAR and IA. 
In addition, we found increased ceramide accumulation in the infarcted area 
of the heart. Thus, our results indicate that lipid accumulation in the heart is 
one of the metabolic derangements remaining after ischemia, even in the 
myocardium bordering the infarct area.    
 
In this paper, we investigated the role of Plin5 in myocardial lipid dynamics, 
cardiac function, and outcome after myocardial ischemia. Here, we studied 
the impact of polymorphism in the PLIN5 gene following myocardial 
ischemia in human subjects followed by mechanistic studies of the role of 
Plin5 in lipid metabolism and cardiac function in Plin5 deficient mice.   
 
We could show that a single nucleotide polymorphism in the PLIN5 gene 
was associated with impaired heart function following myocardial ischemia, 
indicating that PLIN5 function is relevant to human cardiac physiology.  
 
In the Plin5
–/– 
mouse hearts, we found dramatically decreased levels of 
triglycerides and a small decrease in diglycerides compared to the WT. 
However, no other lipid species was affected. Interestingly, the cardiac fatty 
acid uptake was diminished in the Plin5
–/–
 mice and the incorporation into 
triglycerides was almost abolished, suggesting a compensatory inhibition of 
the fatty acid uptake due to the decreased lipid storage capacity of the Plin5
–/–
 
hearts. Further, we could show an increased uptake of glucose in the Plin5
–/– 
hearts and an increased utilization of glucose in isolated Plin5
–/–
 hearts 
compared to WT. Thus, our data indicates that Plin5
–/–
 hearts have altered 
substrate preference and shift from fatty acids to glucose utilization.    
   
Plin5 have been shown in silico to possess a mitochondrial recruitment 
domain. In agreement with this, we observed in vivo that the distance 
between the lipid droplets and the mitochondria was increased in the Plin5
–/–
 
hearts compared to the WT hearts. In addition, we found that mitochondria 
isolated from Plin5 deficient hearts had a reduced membrane potential and a 
slightly reduced ATP production from succinate and pyruvate. Lipidomic 
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analysis of the isolated mitochondrial membrane from WT and Plin5
–/–
 hearts 
revealed an altered fatty acid composition of PC and PE in the Plin5 deficient 
mice. Thus, the altered fatty acid length in the mitochondria of Plin5
–/–
hearts 
may explain the reduced mitochondrial potential. 
  
We assessed how the altered metabolism in the Plin5 deficient mice affects 
the heart function using ultrasound. The heart function during baseline 
conditions was close to normal in the Plin5
–/–
 mice compared with the WT 
mice. However, when stressing the WT and Plin5
–/–
hearts with the β-
adrenergic agonist dobutamine, the heart function was severely reduced in the 
Plin5
–/–
 mice. Further, deficiency of Plin5 resulted in a reduced survival after 
an induced myocardial infarction. Thus, our data indicates that Plin5
–/–
 mice 
maintain a relatively normal heart function under baseline conditions, but 
their cardiac function is significantly reduced after hormonal or ischemic 
stress, resulting in increased mortality.  
 
We hypothesized that the Plin5
–/–
 mice are in a state of low substrate 
availability after myocardial ischemia. Therefore, we investigated the 
palmitate oxidation in isolated hearts in a model low flow and of high 
workload. We found a trend towards a decreased glycolysis in the Plin5
–/–
 
hearts in the model low flow. However, a model of high work load is more 
representative to our situation after an induced myocardial ischemia. In this 
model, we found that Plin5
–/–
 hearts had slightly decreased substrate 
utilization from palmitate compared with WT hearts. In addition, when 
investigating the glycogen stores after myocardial infarction we found that 
the glycogen was almost abolished in the non-infarct areas in the Plin5
–/–
 
hearts. This suggests that the reduced substrate availability force Plin5
–/–
 
hearts to use the endogenous glycogen stores for energy. Consequently, our 
results indicate that Plin5
–/– 
hearts have reduced substrate availability, 
resulting in inefficient energy utilization. 
 
In conclusion, our results suggest that Plin5 regulates the metabolic 
flexibility of the heart and plays a key role in cardioprotection during 
myocardial ischemia. 
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In this paper, we investigated the role of Plin2 in myocardial lipid 
metabolism, heart function and outcome after an induced myocardial 
infarction. 
 
Here, we studied the lipid droplet protein Plin2 in HL1 cardiomyocytes and 
Plin2
–/–
 mice. First, we analyzed the expression pf Plin2 after oleic acid 
treatment of HL1 cells. The mRNA expression of Plin2 was unchanged after 
oleic acid supplementation. However, the protein expression was increased 
after treatment. In agreement with previous studies, this indicates that the 
protein is stabilized by increased lipid accumulation. 
 
Since deficiency of Plin5 resulted in dramatically reduced triglyceride 
content, we analyzed the lipid content in the hearts of the Plin2
–/–
 mice. 
Surprisingly, we found markedly increased levels of triglycerides. One 
hypothesis was that the increased triglyceride accumulation was due to an 
elevated lipid uptake. However, the circulating levels of fatty acids and 
triglycerides were unaltered suggesting that the increased triglyceride content 
in the heart was not caused by an elevated availability of plasma lipids. 
Further, although we found increased expression of PPARγ, we did not 
observe a concomitant increase in the PPARγ regulated fatty acid 
transporters CD36 and FABP. We continued by analyzing the uptake of oleic 
acid, glucose and VLDL in control and Plin2 knockdown HL1 cells. 
However, our results showed that Plin2 deficiency does not alter the substrate 
uptake in HL-1 cardiomyocytes.  Next, we wanted to repeat the fatty uptake 
studies in vivo using Plin2
–/–
 mice. In agreement with the cell culture studies, 
we found that there were no differences in the uptake of fatty acids in the 
hearts of WT and Plin2
–/–
 mice. There was also no difference in ability to 
incorporate palmitate into triglycerides. Our findings show that the increased 
amount of triglycerides in the Plin2–/– hearts is not due to increased uptake of 
fatty acids. Further investigations are needed to elucidate potential 
differences in lipid uptake, e.g. LPL mediated VLDL uptake.  
 
Lipid droplets in the heart are also coated with Plin3, 4, and 5. Therefore, we 
analyzed the expression of these perilipins in the WT and Plin2–/– hearts. 
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Interestingly, the protein expression of Plin3 and Plin5 was significantly 
increased in the Plin2
–/–
 hearts compared to WT. These findings indicate the 
Plin2 deficient heart compensates for the absence of Plin2 by upregulating 
the levels of other perilipins.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
    
Finally, we examined whether the deficiency in Plin2 affected the heart 
function. We did not find any difference between the WT and Plin2
–/–
 
 
mice 
under baseline conditions or after dobutamine stress. However, the heart 
function was compromised after an induced myocardial infarction.   
 
In conclusion, our results indicate that Plin2 is important for myocardial lipid 
storage and plays a role for cardiac function following myocardial ischemia. 
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In paper I, we showed that lipids accumulate in the porcine myocardium 
following myocardial ischemia mediated by LDLr and LRP1. In paper II and 
III, we proceeded to investigate the consequences of an altered lipid storage 
regarding lipid metabolism, heart function and outcome after myocardial 
ischemia. In order to investigate altered lipid storage capacity, we used two 
different models of genetically modified mice deficient in the lipid droplet 
proteins Plin2
 
and Plin5. 
Key findings of this study as well as questions beyond the individual papers 
will be discussed in this section. 
 
   
 
Myocardial ischemia is associated with alterations in cardiac metabolism and 
has been reported to promote lipid accumulation in the heart.
24,
 
44
 
 
We have shown that cholesteryl esters accumulate in the heart of our porcine 
model of ischemia/reperfusion. We found an increased expression of LDLr 
and LRP1 in the infarct area and the ischemic area bordering the infarct area 
(AAR). Whether the bulk of the cholesterol uptake is mediated via LDLr or 
LRP1, or a combination of both is a matter of speculation. LRP1 and 
cholesteryl esters have previously been shown to be upregulated in pig heart 
following 90 min of ischemia without reperfusion.
45
 The LRP1 gene has been 
reported to contain two hypoxia responsive elements, indicating that hypoxia 
induced expression HIF1α are involved in the upregulation of LRP1.132 In 
addition, we have analyzed the pig LDLr promoter for HIF1α binding sites 
and did identify one site in the LDLr promoter at position +10 (data not 
shown). However, the HIF1α site did not have a corresponding site in the 
promoters of mice and humans and the significance of this site is uncertain. 
Alternatively, the increased expression of LDLr in our model may be due to 
reperfusion of the heart following ischemia. Reperfusion induces 
inflammation and in agreement with this, we have reported markedly 
increased expression of IL-1β in the ischemic areas of the pig heart. IL-1β 
has previously been shown to disrupt the feedback mechanism that 
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downregulates the LDLr expression in response to high intracellular 
cholesterol levels.
133
 This resulted in an excess of LDL uptake via the 
vascular smooth muscle cells. However, further studies in vivo are required to 
elucidate if inflammation is a mediator of increased cardiac LDLr expression. 
Altogether, HIF1α and inflammation could be important inducers of 
lipoprotein receptor expression following ischemia-reperfusion in pig heart, 
resulting in elevated levels of cholesteryl esters.      
 
We see a similar increase in cholesteryl esters in mouse hearts compared to 
pig hearts following myocardial ischemia (data not shown). In contrast, 
increased cardiac content of triglycerides following myocardial ischemia was 
observed in mice but not in our porcine model. Accumulation of excess 
cholesteryl esters may be detrimental for the heart function. Excess of free 
cholesterol results in high membrane rigidity, which is toxic to the cell. The 
liver can eliminate excess cholesterol via the bile.
134
 The heart lacks such 
effective elimination pathways and regulates the levels of free cholesterol 
mainly by uptake and esterification of cholesterol for storage in lipid droplet. 
Indeed, high cholesterol diet has been shown to result in an increased 
membrane cholesterol content and systolic and diastolic dysfunction.
135
 
Further, the accumulation of lipids, including cholesteryl esters, in the 
myocardium have been associated with dilated cardiomyopathy.
136
 Thus, 
pharmaceutical targeting of cholesteryl ester accumulation in heart following 
myocardial ischemia is an interesting future research area.  
   
In addition to accumulation of cholesteryl esters, we could show increased 
levels of ceramides in the infarcted area. Ceramides are considered as 
bioactive lipids and can cause cellular dysfunction and apoptosis following 
myocardial ischemia.
55
 In agreement with our results, ischemia has been 
reported to increase levels of ceramides.
24, 55, 137
 In contrast, ischemia with a 
subsequent reperfusion further increased ceramide accumulation in the 
heart.
55, 137
 We did observe elevated levels of ceramides in the infarct area, 
but interestingly not in the ischemic area bordering the infarction (AAR). 
Whether ceramide levels were normalized after 4 hours of reperfusion or did 
not increase at all in the peri-infarct zone remains to be elucidated  
Our results indicate that accumulation of cholesteryl esters and ceramides in 
the heart is one of the metabolic derangements remaining after ischemia. 
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Normalizing lipid levels in the myocardium after ischemia would likely 
improve myocardial function and should be considered as a target for 
treatment. 
 
Neutral lipids are stored in lipid droplets which are coated with numerous 
proteins with various functions. In the heart, the lipid droplet proteins Plin2 
and Plin5 are of importance for the function and protection of the lipid 
droplet. Genetic deletion of Plin5 and Plin2 in mice thus provided us with 
models for studying the influence of altered lipid storage capacity on lipid 
metabolism, heart function and outcome after myocardial ischemia.  
 
Deficiency of Plin5 results in dramatically lowered levels of triglycerides in 
the myocardium. This result was expected, since one of the roles of Plin5 is 
to protect the lipid droplets against lipases. Indeed, the lipid droplets in the 
cardiomyocytes of the Plin5
–/–
 mice were smaller and fewer compared to the 
lipid droplets in the WT. However, deficiency of Plin2 unexpectedly resulted 
in increased levels of cardiac triglycerides. In contrast, previous studies in 
Plin2
–/–
 mice have reported decreased lipid accumulation in the liver.
92,
 
93
 The 
increased triglyceride levels in the heart of our Plin2
–/–
 mice was not the 
result of increased fatty acid uptake; the plasma levels of triglycerides did not 
differ between the WT and Plin2
–/–
 mice and no increased fatty acid uptake 
was observed in Plin2
–/–
 hearts. However, the protein expression of Plin5 and 
Plin3 was increased in the Plin2 deficient hearts. This finding is in agreement 
with previous reports showing that Plin5 protein is upregulated in the liver of 
Plin2
–/–
 mice lacking leptin.
138
 These results suggest that Plin3 and Plin5 are 
more protective against lipases than Plin2 in the heart. However, if and how 
additional Plin3 and Plin5 are recruited to the lipid droplet from the cytosol 
in the absence of Plin2 should be further studied. Also, the possibility of an 
increased lipid accumulation resulting in elevated levels of Plin3 and Plin5 
cannot be excluded. A reduction in lipid oxidation or an increased uptake of 
other lipid sources than albumin-bound fatty acids Plin2
–/–
 hearts would 
result in increased lipid content. 
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The Plin5
–/–
 mice had decreased levels of cardiac triglycerides whereas the 
Plin2
–/–
 mice instead displayed increased levels of triglycerides. However, the 
outcome following myocardial ischemia was similar. The Plin5
–/–
 mice had 
severely reduced heart function after dobutamine stress and a reduced 
survival following myocardial infarction. We have shown that Plin5 
facilitates the association between the lipid droplet and the mitochondria. 
This connection between the storage and utilization of lipids is of crucial in 
the heart that has a high and fluctuating energy demand. The Plin5
–/–
 mice 
hearts have a diminished contact between mitochondria and lipid droplets 
combined with a reduced storage pool of lipids. Thus, our data suggest that 
the Plin5
–/–
 mice have reduced substrate availability, resulting in increased 
mortality following myocardial ischemia. Plin2 deficiency resulted in a 
milder heart phenotype than the Plin5 deficient hearts with a normal heart 
function at baseline and after dobutamine stress. However, the Plin2
–/–
 mice 
had a compromised heart function compared to the WT mice following 
myocardial ischemia. Levels of cardiac ceramide, triglycerides and 
cholesteryl esters were increased to similar levels in Plin2
–/–
 
 
and WT mice 
following ischemia, indicating lipotoxic aggravation of heart function to be 
less likely in the Plin2
–/– 
mice.  
 
Our data indicates that deficiency in Plin2 or Plin5 results in a compromised 
heart function although through different mechanisms. Although Plin5 is the 
most important lipid droplet protein in the normal heart, a balance between 
perilipins on the lipid droplet may be of importance for its proper function. A 
study in human skeletal muscle suggests a preferential utilization of Plin2 
coated lipid droplets during moderate-intensity exercise.
139
 It remains to be 
examined if this also occurs in the surviving part of the left ventricle after 
myocardial ischemia which experiences a high work load. Plin5 deficiency 
and a decreased triglyceride pool resulted in reduced lipid utilization and 
heart function at a high workload. The processes of storage and utilization of 
lipids are closely connected; therefore, lack of Plin2 on lipid droplets most 
likely also alters the flux and utilization of lipids and by that influences the 
heart function following myocardial ischemia 
 
Altogether, our data shows that presence of lipid droplet proteins and a 
functional regulation of lipid droplets are crucial for the function of the 
ischemic heart.   
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Cardiac lipid droplets play an important role in balancing the fluctuations in 
lipid availability and requirements of metabolic energy. However, little is 
known of the interplay between the lipid storage and lipid uptake.  
 
The Plin5 deficient mouse heart displayed smaller and fewer lipid droplets 
compared to the WT mice and thus had decreased storage capacity. The first 
assumption would be that more fatty acids is shunted towards β-oxidation 
However, we could show that β-oxidation is unchanged. Interestingly, the 
fatty acid uptake is decreased in the Plin5 deficient hearts. This suggests that 
the heart of the Plin5
–/–
 mice can adjust its fatty acid uptake in order to 
compensate for the decreased storage capacity. The mechanism to lower the 
fatty acid uptake remains to be elucidated. The altered lipolysis of the 
triglyceride pool in Plin5
 
deficient hearts likely changes the available amount 
and of fatty acids in the cardiomyocyte. These fatty acids can act as ligands to 
PPARs which in turn activates genes involved in lipid metabolism, including 
lipid uptake. Alteration of lipolysis by both deletion and overexpression of 
ATGL in mice has been shown to reduce cardiac expression of PPARα/δ 
target genes.
140,
 
141
 Thus, decreased or increased activation of PPARs in the 
Plin5
–/–
 mice compared to the WT may contribute to the decreased fatty acid 
uptake. In agreement with this hypothesis, the mRNA expression of CD36 is 
decreased in the myocardium of the Plin5
–/–
 mice. The uptake of fatty acids is 
induced by a translocation of CD36 from intracellular compartments to the 
sarcolemma. Most stimuli that translocate of GLUT4 to the sarcolemma, such 
as contraction, AMPK and insulin signaling, similarly affect CD36 
translocation.
33
 Interestingly, we observed a reduced uptake of fatty acids in 
the hearts of Plin5
–/–
 mice whereas the glucose uptake was increased. 
Similarly, a differential translocation of CD36 and GLUT4 was reported in a 
model of global ischemia in isolated hearts.
22
 Thus, regulation of GLUT4 and 
CD36 translocation can occur by different mechanisms. This regulation may 
involve signaling pathways or the subcellular trafficking machinery involved 
in the translocation of CD36 and GLUT4. Cytoskeleton reorganization, v-
ATPases (regulating endosomal acidification), Rab and SNARE proteins 
have been reported to be essential for the translocation process.
33
 Further 
research is required to investigate how absence of Plin5 results in differential 
lipid and glucose uptake.   
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Interestingly, our results suggest that hearts with diminished capacity to store 
lipids can compensate by markedly decreasing fatty acid uptake. The lipid 
uptake may be regulated by signaling though fatty acids or by the subcellular 
trafficking machinery of CD36 translocation.   
 
The induction of a myocardial infarction by ligation of a coronary artery 
results in ischemia in the part of the heart normally supplied by the ligated 
artery. Thus, the infarction induces a substantial stress on the heart function.  
 
Our Plin5 deficient mice had a reduced survival following myocardial 
ischemia compared to the WT mice. The infarct size after an induced 
myocardial infarction was comparable between the WT and Plin5
–/–
 mice, 
indicating that Plin5 deficiency did not play an important role in the 
expansion and size of the infarct area. In agreement with this, we found that 
patients carrying a polymorphism in the PLIN5 gene responded worse to 
ischemia, but the genetic variation did not give rise to increased ischemia. 
Following a myocardial infarction, the ischemic and subsequent infarcted 
area is unable to contract resulting in a highly increased workload of the 
surviving left ventricle. The increased workload results in a higher energy 
demand of the heart. This is detrimental for the Plin5
–/–
 hearts, because of 
their reduced energy substrate availability. 
 
Thus, our data suggests that deficiency of Plin5 and the resulting reduction in 
substrate availability and ineffective substrate utilization in the non-ischemic 
left ventricle resulting in reduced survival.      
 
The healthy heart primarily uses fatty acids to produce ATP, but is able to 
shift substrate preference due to physiological and pathological challenges. 
For instance, the ischemic or failing heart shifts from fatty acid oxidation 
towards glucose utilization. A general consensus has considered this shift to 
be a beneficial oxygen-sparing mechanism for the heart. However, oxidation 
of fatty acids is far more energy efficient compared other energy substrates, 
thus, a large amount of glucose is needed to compensate for a decrease in 
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fatty acid oxidation. This suggests a shift from fatty acid oxidation to be less 
beneficial to the ischemic/failing heart.  
 
We could show that Plin5 deficiency resulted in a reduced myocardial 
triglyceride pool. In baseline conditions, the Plin5
–/–
 mice could compensate 
by increasing substrate utilization from glucose, and by that preserving the 
energy balance. However, during high workload the isolated Plin5
–/–
 heart 
had a decreased utilization from fatty acids and a severely reduced heart 
function. There are mouse models investigating changes in fatty acid 
oxidation, e.g. LCAD
–/–
 mice. Deletion of LCAD
 
results in deficient 
mitochondrial long-chain fatty acid β-oxidation. In the fed state, these mice 
relied on glucose oxidation and had a normal energy status.
142
 However, 
during fasting when the heart normally depends almost exclusively on fatty 
acid oxidation,
34
 the LCAD
–/– 
mice instead had a sustained glucose uptake 
compared to the fed state. However, this was insufficient to maintain the 
energy status resulting in reduced cardiac performance.
142
 Together, this 
indicates that fatty acid utilization and a cardiac metabolic flexibility is 
crucial to maintain heart function.  
 
Whether cardiac lipid accumulation is unfavorable for the heart is debated. 
Our Plin5 deficient mice have a reduced content of triglycerides and 
diglycerides and, interestingly, unaltered levels of ceramides. Heart function 
is severely reduced during stress in the Plin5
–/–
 mice. There are other mouse 
models with altered lipid storage. Deletion of the lipase ATGL results in 
severe accumulation of lipids, reduced cardiac fatty acid oxidation, and lethal 
cardiomyopathy.
141,
 
143
 On the other hand, overexpression of DGAT1, which 
catalysis the syntheses of triglycerides from diglycerides, also results in an 
increased content of triglycerides. However, the content of ceramides and 
diglycerides was reduced and the cardiac function was unaffected.
51
 Thus, 
this indicates that the lipid dynamics and metabolism are important for the 
maintenance of cardiac function and not levels of cardiac lipids per se.  
 
In conclusion, a maintained energy efficient fatty acid oxidation is favorable 
in stress conditions.     
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Here, the clinical implications of our results will be discussed. We have 
studied the role of Plin5 in a human cohort showing that Plin5 influences 
cardiac functions in humans. This suggests that targeting of lipid droplet 
proteins could potentially be a strategy to develop novel pharmaceutical 
treatment. In addition, our studies on lipid storage and metabolism following 
myocardial ischemia in mice contribute to the development of future cardiac 
metabolic therapies for cardiovascular diseases.  
 
Our results show that Plin5 influences cardiac functions in humans. A single 
nucleotide polymorphism in the PLIN5 gene was associated with impaired 
heart function following myocardial ischemia in patients with suspected 
coronary artery disease.  The carriers of the minor allele of the SNP had 
slightly lower gene expression of Plin5. In the future, identifying low levels 
of Plin5 in patients with high risk of cardiovascular disease would represent a 
promising approach to decrease morbidity and mortality in this population.  
 
The non-ischemic part of the left ventricle has an increased cardiac workload 
following myocardial ischemia, similar to the situation in the failing heart. 
Thus, our studies regarding storage and utilization of lipids in the non-
ischemic parts following myocardial ischemia also contribute to the research 
field of heart failure. At present, pharmacological treatment of heart failure 
with neurohormonal antagonists, such as β-adrenergic blockers and 
angiotensin-receptor blockers, has successfully reduced heart failure 
mortality. However, the remaining disability and death rate remain high.
144
 
Because of the high energy consumption of the heart, even small variations in 
the efficiency of energy generation or utilization may have profound effect on 
cumulative energy levels in the cardiomyocyte. Thus, cardiac metabolic 
therapies represent promising targets for heart failure therapy.
144,
 
145
  
 
The shift from fatty acid oxidation towards glucose utilization in the failing 
heart has been considered being a beneficial oxygen-sparing mechanism. 
Thus, metabolic therapies aiming to promote glucose oxidation have been 
tested. Enhancing glucose utilization in the ischemic and failing heart have 
been reported to improve cardiac function and symptoms of heart failure in 
the short term.
13
 Dichloroacetate (DCA) promotes glucose oxidation by 
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inhibiting pyruvate dehydrogenase kinase (PDK). DCA treatment has been 
shown to improve recovery during reperfusion and also to improve cardiac 
function in right ventricular hypertrophy in multiple animal models.
146, 147,
 
148
 
However, human studies have reported inconsistent results regarding cardiac 
improvements of DCA treatment and long-term clinical trials have never 
been performed.
149
  
 
On the other hand, reducing fatty acid supply to failing hearts seems to be 
harmful in spite of increased glucose uptake. The nicotinic acid derivative 
acipimox inhibits lipolysis in adipose tissue and by that decreases the 
circulating levels of fatty acids. Treatment with acipimox in patients with 
cardiomyopathic heart failure decreased fatty acid uptake by >80% and 
enhanced glucose uptake. However, this resulted in a reduction in cardiac 
work and efficiency.
150
 Further, modulation of cardiac fatty acid utilization 
has been a target of metabolic therapy in heart failure. One target has been 
CPT1, the enzyme responsible for long chain fatty acid uptake in the 
mitochondria. Some studies have revealed beneficial effects of CPT1 
inhibition in heart failure.
151
 However, heterozygous CPT1b knockout mice 
showed an aggravated pressure overload-induced cardiac hypertrophy,
152
 
inducing concern about the safety and efficacy of CPT1 inhibition in heart 
failure patients. Instead, prevention of the metabolic switch toward glucose 
utilization in the hypertrophic mouse heart and a maintained fatty acid 
oxidation has been proposed to be beneficial to preserve myocardial 
energetics and cardiac function.
153
   
 
Our study shows that a small triglyceride pool and reduced lipid utilization in 
the hearts of high workload is unfavorable to the heart function. Thus, our 
data suggests that pharmacological treatment strategies in order to maintain 
or increase lipid utilization are beneficial to the failing and post-ischemic 
heart.  
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In this study, I have investigated lipid accumulation in a porcine model if 
ischemia/reperfusion. Also, I have studied the consequences of an altered 
lipid storage regarding lipid metabolism, heart function and outcome after 
myocardial ischemia. I have reached the following conclusions:  
 
 
o Ischemia/reperfusion in the porcine heart promoted 
cholesteryl ester accumulation mediated by the LDLr and 
LPR1.  
 
o The lipid droplet protein Plin5 regulates metabolic flexibility 
of the heart and plays a key role in cardioprotection during 
myocardial ischemia. 
 
o The lipid droplet protein Plin2 is important for myocardial 
lipid storage and plays a role for cardiac function following 
myocardial ischemia. 
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